[go: up one dir, main page]

Griffiths et al., 2023 - Google Patents

Sterol Lipids

Griffiths et al., 2023

Document ID
7947519666358256109
Author
Griffiths W
Yutuc E
Wang Y
Publication year
Publication venue
Mass Spectrometry for Lipidomics: Methods and Applications

External Links

Snippet

Sterol lipids were one of the first categories of biomolecules to be investigated using mass spectrometry. They represent a broad range of molecules starting with C 30 lanosterol, or cycloartenol in organisms of photosynthetic linage, proceeding through cholesterol in …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor

Similar Documents

Publication Publication Date Title
Karu et al. Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols
Griffiths et al. Analysis of oxysterols by electrospray tandem mass spectrometry
Crick et al. Quantitative charge-tags for sterol and oxysterol analysis
Griffiths et al. Analysis of oxysterol metabolomes
Schänzer et al. Mass spectrometric identification and characterization of a new long‐term metabolite of metandienone in human urine
Meljon et al. Analysis of bioactive oxysterols in newborn mouse brain by LC/MS
Santa Derivatization reagents in liquid chromatography/electrospray ionization tandem mass spectrometry
Zhang et al. Key regulatory oxysterols in liver: analysis as Δ4-3-ketone derivatives by HPLC and response to physiological perturbations
Griffiths et al. Cholesterolomics: an update
Karu et al. Nano-liquid chromatography–tandem mass spectrometry analysis of oxysterols in brain: monitoring of cholesterol autoxidation
Griffiths et al. Metabolomics and metabolite profiling: past heroes and future developments
US9851368B2 (en) Kit and method for quantitative detection of steroids
Ayciriex et al. Development of a novel method for quantification of sterols and oxysterols by UPLC-ESI-HRMS: application to a neuroinflammation rat model
Gómez et al. Detection and characterization of urinary metabolites of boldione by LC‐MS/MS. Part I: Phase I metabolites excreted free, as glucuronide and sulfate conjugates, and released after alkaline treatment of the urine
Meljon et al. Analysis by liquid chromatography–mass spectrometry of sterols and oxysterols in brain of the newborn Dhcr7Δ3-5/T93M mouse: A model of Smith–Lemli–Opitz syndrome
Piper et al. Studies on the in vivo metabolism of the SARM YK11: Identification and characterization of metabolites potentially useful for doping controls
Wang et al. 24S, 25-Epoxycholesterol in mouse and rat brain
Abdel-Khalik et al. Identification of 7α, 24-dihydroxy-3-oxocholest-4-en-26-oic and 7α, 25-dihydroxy-3-oxocholest-4-en-26-oic acids in human cerebrospinal fluid and plasma
Wang et al. Targeted lipidomic analysis of oxysterols in the embryonic central nervous system
Crick et al. The oxysterol and cholestenoic acid profile of mouse cerebrospinal fluid
Griffiths et al. Sterolomics in biology, biochemistry, medicine
Wang et al. Mass spectrometry based on chemical derivatization has brought novel discoveries to lipidomics: A comprehensive review
Wang et al. On-tissue chemical oxidation followed by derivatization for mass spectrometry imaging enables visualization of primary and secondary hydroxyl-containing metabolites in biological tissues
Griffiths et al. Sterol Lipids
Parr et al. Metabolism of androsta‐1, 4, 6‐triene‐3, 17‐dione and detection by gas chromatography/mass spectrometry in doping control